Abstract
To assess the efficacy, safety, and tolerability of fesoterodine 4 and 8 mg in men with overactive bladder. This was a subanalysis of pooled data from 358 men enrolled in 2 double-blind, placebo-controlled phase III trials. Subjects with frequency and urgency or urgency urinary incontinence (UUI) were randomized to fesoterodine 4 mg, fesoterodine 8 mg, or placebo for 12 weeks. Efficacy endpoints included bladder diary variables and subject-reported treatment response. By week 12, men treated with fesoterodine 4 or 8 mg had significantly greater median percentage improvements in micturition frequency, urgency episodes, and UUI episodes versus placebo and significantly greater percentages reported a treatment response versus placebo. Significant increases in mean voided volume (MVV) per micturition versus placebo occurred with fesoterodine 8 mg only. At week 12, fesoterodine 8 mg was significantly more efficacious than fesoterodine 4 mg in improving UUI episodes and MVV per micturition. The most commonly reported adverse events with fesoterodine 4 and 8 mg were dry mouth (12.5% and 37.7% vs 5.6% with placebo) and constipation (2.5% and 8.8% vs 0.8% with placebo). Symptoms suggestive of urinary retention were reported in 0.8%, 0.8...Continue Reading
References
Jun 9, 1992·Biochemical Pharmacology·A GómezF Sanchez de la Cuesta
Mar 1, 1997·The Journal of Urology·T J PetersJ W Thüroff
Jul 18, 2001·The Journal of Urology·M J HymanJ G Blaivas
Sep 17, 2002·Neurourology and Urodynamics·Rintaro MachinoTomohiko Koyanagi
May 29, 2003·The Journal of Urology·A AthanasopoulosG Barbalias
Jun 18, 2003·World Journal of Urology·W F StewartA J Wein
Oct 13, 2004·BJU International·Ji Youl LeeMichael B Chancellor
Nov 11, 2005·The Journal of Urology·Steven A KaplanAlexis E Te
Feb 14, 2006·The Journal of Urology·Paul AbramsRichard Millard
Mar 15, 2006·European Urology·Christopher R Chapple, Claus G Roehrborn
Apr 29, 2006·BJU International·Claus G RoehrbornZhonghong Guan
Aug 15, 2006·Urology·Steven A KaplanZhonghong Guan
Oct 4, 2006·Current Urology Reports·Rodney A Appell
Oct 20, 2006·European Urology·Debra E IrwinPaul Abrams
Nov 14, 2006·European Urology·Roger DmochowskiZhonghong Guan
Nov 16, 2006·JAMA : the Journal of the American Medical Association·Steven A KaplanZhonghong Guan
Jul 27, 2007·European Urology·Christopher ChappleMarina Brodsky
Oct 17, 2007·The Journal of Urology·Victor W NittiTamara Bavendam
Mar 8, 2008·European Urology·Matthias OelkeKlaus Höfner
Mar 18, 2008·Urology·Vik KhullarZhonghong Guan
May 31, 2008·BJU International·Steven A KaplanZhonghong Guan
Jun 20, 2008·BJU International·Con J KelleherZoe Kopp
Jun 24, 2008·Expert Opinion on Pharmacotherapy·Martin C Michel
Jul 22, 2008·The Journal of Urology·Eric S RovnerZhonghong Guan
Aug 30, 2008·Urology·S ColmanU Massow
Sep 9, 2008·Mayo Clinic Proceedings·Scott A MacDiarmidVictor W Nitti
Dec 17, 2008·European Urology·Christopher ChappleZhonghong Guan
Aug 18, 2009·The Journal of Urology·Elisa Martín-MerinoClaus G Roehrborn
Aug 21, 2009·Neurourology and Urodynamics·W F StewartA Dilley
Aug 5, 2011·International Journal of Impotence Research·J Y LeeS W Lee
Jan 1, 2006·Neurourology and Urodynamics·Paul AbramsPeter Sand
Citations
Feb 18, 2011·World Journal of Urology·Matthias OelkeMartin C Michel
Nov 16, 2013·Current Opinion in Urology·João SilvaFrancisco Cruz
Jul 12, 2012·Der Urologe. Ausg. A·F StrittmatterC Gratzke
Nov 1, 2015·Der Urologe. Ausg. A·K HöfnerT Bschleipfer
Nov 12, 2013·Expert Opinion on Drug Metabolism & Toxicology·Stephen Mock, Roger R Dmochowski
Oct 30, 2013·Current Medical Research and Opinion·Howard B GoldmanFady Ntanios
Mar 25, 2011·Current Medical Research and Opinion·Jacques CorcosUNKNOWN Fesoterodine Assessment and Comparison Versus Tolterodine (FACT) Study Group
Mar 2, 2011·Current Medical Research and Opinion·Harriette ScarperoMartin Carlsson
Mar 24, 2015·Current Medical Research and Opinion·Christopher ChappleAdrian S Wagg
Mar 6, 2013·Neurourology and Urodynamics·Adrian WaggCaty Ebel Bitoun
Dec 15, 2015·International Journal of Surgery·Haitham AbdelmotelebMarcus J Drake
Apr 2, 2013·European Urology·Matthias OelkeUNKNOWN European Association of Urology
Jan 8, 2011·International Journal of Clinical Practice·S A KaplanZ Guan
Jul 6, 2013·BJU International·David GinsbergDiane L Martire
Oct 5, 2011·BJU International·Steven A KaplanZhonghong Guan
Jul 6, 2015·Urology·Matthias OelkeCharalampos Mamoulakis
Jul 18, 2014·Prostate International·Seung Hwan Lee, Ji Youl Lee
Jul 25, 2012·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·V SchulerU von Mandach
Aug 1, 2016·The Urologic Clinics of North America·Nadir I OsmanChristopher R Chapple
Jan 20, 2012·The Cochrane Database of Systematic Reviews·Priya MadhuvrataE Jean C Hay-Smith
Feb 2, 2018·BMC Complementary and Alternative Medicine·Niikee SchoendorferKiran D K Ahuja
Jan 17, 2017·Current Urology Reports·Matthew C MossAlex Gomelsky
Feb 18, 2021·Deutsches Ärzteblatt International·Arkadiusz Miernik, Christian Gratzke